What was the primary purpose of this debt issuance?

While not explicitly stated as the sole purpose in this 8-K, the debt issuance of $6.2 billion was closely linked to Becton Dickinson's then-pending acquisition of CareFusion Corporation. Such large debt issuances are typically used to finance major strategic initiatives like acquisitions, as well as for general corporate purposes or to refinance existing debt.

What are the key risks associated with these new notes for investors?

A primary risk highlighted is the 'special mandatory redemption' provision. If the CareFusion acquisition does not proceed as planned (i.e., not consummated by October 5, 2015, or if the agreement is terminated), the company must redeem all notes at a premium (101% of principal). This introduces uncertainty regarding the long-term holding of these notes if the acquisition fails. Additionally, standard credit risks related to BDX's financial health and operational performance apply.

What does a 'Change of Control Trigger Event' mean for these notes?

A 'Change of Control Trigger Event' gives bondholders the right to demand that BDX repurchase their notes. If such an event occurs, the company must purchase all or a portion of the holder's notes at 101% of the principal amount, plus accrued interest, unless the notes have already been redeemed by BDX. This protects bondholders in situations where a significant change in the company's ownership or control might impact their investment.

What are the interest rates and maturities of the notes issued?

BDX issued five series of notes: Floating Rate Notes due June 15, 2016; 1.800% Notes due December 15, 2017; 2.675% Notes due December 15, 2019; 3.734% Notes due December 15, 2024; and 4.685% Notes due December 15, 2044. The total aggregate principal amount issued was $6.2 billion.

BDX 8-K: Financial Events

Summary

Becton Dickinson and Company (BDX) filed an 8-K on December 15, 2014, to report the issuance of a substantial amount of debt through a public offering. The company raised a total of $6.2 billion across five series of notes with varying maturities and interest rates. This debt issuance is a significant event, indicating a large capital raising activity by BDX. Investors should note the specific terms and conditions associated with these new notes, including redemption provisions and potential mandatory redemption events related to the then-pending acquisition of CareFusion Corporation. The filing details the various note series, including Floating Rate Notes due 2016, and fixed-rate notes maturing in 2017, 2019, 2024, and 2044. A key aspect for investors is the 'special mandatory redemption' clause, which would trigger a redemption at 101% of the principal amount if the CareFusion Acquisition does not close by October 5, 2015, or if the merger agreement is terminated. This highlights a direct financial link between the debt issuance and the strategic acquisition, posing a potential risk or restructuring event for bondholders if the acquisition were to falter.

Key Highlights

1BDX issued $6.2 billion in aggregate principal amount of debt across five note series on December 15, 2014.
2The notes have maturities ranging from June 2016 to December 2044, with fixed interest rates and one floating-rate series.
3A significant portion of the debt issuance is directly tied to the potential acquisition of CareFusion Corporation.
4The company may be required to redeem all notes at 101% of their principal amount if the CareFusion Acquisition does not close by October 5, 2015, or if the merger agreement is terminated.
5Bondholders have the right to require BDX to purchase their notes at 101% of the principal amount upon a 'Change of Control Trigger Event'.
6The filing outlines standard events of default and acceleration provisions under the indenture, common for corporate debt.

BECTON DICKINSON & CO 8-K Report, Financial Obligation (Dec 15, 2014)

Summary

Key Highlights

Frequently Asked Questions